SNT Synektik Spólka Akcyjna
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.…
Industry Peers
Medical DevicesKey Statistics
About Synektik Spólka Akcyjna (WSE: SNT)
›
Synektik Spólka Akcyjna (WSE: SNT) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 231 employees.
The shares were at 307.80 PLN on 20 November 2026, up 48.4% over 52 weeks. Its 52-week range is 201.20 PLN to 388.00 PLN: the price is 20.7% below the high and 53.0% above the low.
At a market capitalisation of 2.63B PLN, it trades at 14.4 times trailing earnings and 25.9 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.5, a discount of 44% for SNT. It pays a dividend yielding 3.40% (it pays out 52% of its earnings), against a median of 2.35% among the dividend payers in that peer group.
Synektik Spólka Akcyjna reports return on equity of 46.0%, an operating margin of 24.1% and revenue up 89.5% year over year.
It holds more cash than debt, a net cash position of 35.73M PLN. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 373.00 PLN is 21.2% above the current price.